CClinicalTrials.gg
Active, not recruitingNCT05959512Updated Aug 20, 2024

Smoking Pattern and Influencing Factors in Hospitalized Patients

An observational study in Smoking Behaviors, sponsored by Beijing Normal University. Active, not recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-20.

Sponsored by Beijing Normal University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This study examines the smoking patterns and determinants of inpatients who smoke, develops tailored smoking cessation interventions based on their individual needs, and aims to enhance the effectiveness of quitting and lower the likelihood of relapse.

Read the detailed description

Smoking is a major risk factor for many chronic and acute diseases, and quitting smoking can bring significant health benefits. However, many smokers find it hard to quit or relapse after quitting. This study aims to explore the smoking behavior and influencing factors of inpatients who smoke. The survey will collect data on the demographic, clinical, psychological, and behavioral aspects of the participants, as well as their smoking history, nicotine dependence, withdrawal symptoms, confidence and motivation to quit, and perceived barriers and facilitators to quitting.

02

Conditions studied

  • Smoking Behaviors
03

In context

Lead sponsor

Beijing Normal University is the lead sponsor of 30 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of hospitalized patients who smoke and meet the following inclusion and exclusion criteria. Inclusion criteria: (1) Aged 18 years or above; (2) Have a history of smoking, smoking ≥1 cigarette per day (3) Willing to participate in this study and sign an informed consent form. Exclusion criteria: (1) Have mental illness or cognitive impairment; (2) Unable to complete the questionnaire survey.

Inclusion criteria

  1. aged 18 and above;
  2. smoke at least 1 cigarette daily;
  3. willing to participate in this study

Exclusion criteria

Exclusion Criteria:

  1. Smokers who have mental illness or cognitive impairment;
  2. Unable to complete the questionnaire survey
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Smoking cessation rate at 6 months after discharge

    The number of participants who quit smoking at 6 months after discharge, verified by carbon monoxide (CO) test

    Time frame: 6 months after discharge

Secondary outcomes

  1. Smoking reduction rate at 6 months after discharge

    The number of participants who reduce their daily cigarette consumption by at least 50% at 6 months after discharge

    Time frame: 6 months after discharge

  2. Quit attempt rate during the 6-month follow-up period

    The number of participants who make at least one quit attempt during the 6-month follow-up period, verified by self-report

    Time frame: 6 months after discharge

07

Study locations

1 site
  • Xue Weng
    Zhuhai, Guangdong 519087, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05959512
Lead sponsor
Beijing Normal University
Responsible party
Sponsor
First posted
Jul 25, 2023
Start date
Jul 19, 2023
Primary completion
Jul 14, 2024
Completion
Dec 30, 2025 (estimated)
Last update
Aug 20, 2024

Study contacts

Xue Weng
principal investigator · Beijing Normal University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion